Morishima Y - Search Results

1

Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy.

Nomoto H, Takami A, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Morishita E. Nomoto H, et al. Among authors: morishima y. Int J Mol Sci. 2019 Jan 8;20(1):214. doi: 10.3390/ijms20010214. Int J Mol Sci. 2019. PMID: 30626079 Free PMC article.

2

Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.

Suzuki R, Murata M, Kami M, Ohtake S, Asou N, Kodera Y, Tomonaga M, Masaki Y, Kusumoto S, Takeuchi J, Matsuda S, Hirai H, Yorimitsu mS, Hamajima N, Seto M, Shimoyama M, Ohno R, Morishima Y, Nakamura S. Suzuki R, et al. Among authors: morishima y. Int J Hematol. 2003 Jun;77(5):482-9. doi: 10.1007/BF02986617. Int J Hematol. 2003. PMID: 12841387

3

Izutsu K, Kanda Y, Ohno H, Sao H, Ogawa H, Miyazaki Y, Kawa K, Kodera Y, Kato S, Morishima Y, Hirai H; Japan Marrow Donor Program. Izutsu K, et al. Among authors: morishima y. Blood. 2004 Mar 1;103(5):1955-60. doi: 10.1182/blood-2003-03-0937. Epub 2003 Nov 6. Blood. 2004. PMID: 14604976 Free article.

4

Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility antigen epitope derived from BCL2A1, ACC-1, in patients receiving HLA genotypically matched unrelated bone marrow transplant.

Nishida T, Akatsuka Y, Morishima Y, Hamajima N, Tsujimura K, Kuzushima K, Kodera Y, Takahashi T. Nishida T, et al. Among authors: morishima y. Br J Haematol. 2004 Mar;124(5):629-35. doi: 10.1111/j.1365-2141.2004.04823.x. Br J Haematol. 2004. PMID: 14871250 Free article.

5

Twenty years' experience in allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in the Nagoya Blood and Marrow Transplantation Group.

Iida H, Sao H, Kitaori K, Gotoh S, Yazaki M, Kojima S, Wakita A, Morishima Y, Kodera Y, Morishita Y. Iida H, et al. Among authors: morishima y. Int J Hematol. 2004 Jan;79(1):79-84. doi: 10.1007/BF02983538. Int J Hematol. 2004. PMID: 14979483 Review.

6

Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study.

Morishima Y, Ogura M, Nishimura M, Yazaki F, Bessho M, Mizoguchi H, Chiba S, Hirai H, Tauchi T, Urabe A, Takahashi M, Ohnishi K, Yokozawa T, Emi N, Hirano M, Shimazaki C, Nakao S, Kawai Y, Fujimoto M, Taguchi H, Jinnai I, Ohno R. Morishima Y, et al. Int J Hematol. 2004 Oct;80(3):261-6. doi: 10.1532/ijh97.04074. Int J Hematol. 2004. PMID: 15540902 Clinical Trial.

7

A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene.

Torikai H, Akatsuka Y, Miyazaki M, Warren EH 3rd, Oba T, Tsujimura K, Motoyoshi K, Morishima Y, Kodera Y, Kuzushima K, Takahashi T. Torikai H, et al. Among authors: morishima y. J Immunol. 2004 Dec 1;173(11):7046-54. doi: 10.4049/jimmunol.173.11.7046. J Immunol. 2004. PMID: 15557202

8

A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantation.

Terakura S, Murata M, Nishida T, Emi N, Akatsuka Y, Riddell SR, Morishima Y, Kodera Y, Naoe T. Terakura S, et al. Among authors: morishima y. Br J Haematol. 2005 Apr;129(2):221-8. doi: 10.1111/j.1365-2141.2005.05427.x. Br J Haematol. 2005. PMID: 15813850 Free article.

9

Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor.

Kanda Y, Sakamaki H, Sao H, Okamoto S, Kodera Y, Tanosaki R, Kasai M, Hiraoka A, Takahashi S, Miyawaki S, Kawase T, Morishima Y, Kato S; Japan Marrow Donor Program. Kanda Y, et al. Among authors: morishima y. Biol Blood Marrow Transplant. 2005 Nov;11(11):881-9. doi: 10.1016/j.bbmt.2005.07.005. Biol Blood Marrow Transplant. 2005. PMID: 16275591 Free article.

10

Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan.

Imamura M, Asano S, Harada M, Ikeda Y, Kato K, Kato S, Kawa K, Kojima S, Morishima Y, Morishita Y, Nakahata T, Okamura J, Okamoto S, Shiobara S, Tanimoto M, Tsuchida M, Atsuta Y, Yamamoto K, Tanaka J, Hamajima N, Kodera Y. Imamura M, et al. Among authors: morishima y. Int J Hematol. 2006 Feb;83(2):164-78. doi: 10.1532/IJH97.05134. Int J Hematol. 2006. PMID: 16513537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

909 results

Search Page